Atricure to present at the seventh annual jmp securities healthcare
conference
West chester, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or af, and systems for the exclusion of the left atrial appendage, today announced that it will present at the seventh annual jmp securities healthcare conference at the peninsula hotel in new york on friday, july 13, 2012. management is scheduled to present at 10:30 a.m. eastern time. a live audio webcast and replay of the presentation will be available for 30 days following the presentation at www.atricure.com. about atricure, inc. atricure, inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue for the treatment of atrial fibrillation, or af, and systems for the exclusion of the left atrial appendage. for more information, please visit www.atricure.com.
ATRC Ratings Summary
ATRC Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission